Saghmos Therapeutics, Inc. — Form D

Saghmos Therapeutics, Inc. of Greenwich, CT, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-17. The offering totals $7.0M, of which $3.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-04-17
• Form: D
• Accession: 0001737368-18-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $7.0M
• Amount sold: $3.5M
• Remaining: $3.5M
• Investors: 5
• Date of first sale: 2017-08-10
• Security types: equity, debt
• Revenue range: Decline to Disclose
• SEC file number: 021-310295

Issuer

• Name: Saghmos Therapeutics, Inc.
• CIK: 0001737368
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 15 East Putnam Avenue, Greenwich, CT, 06830-5424
• Phone: 914-522-3885

Officers, directors & promoters (2)

More

• CIK 1737368 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search